Medhat W. Shafaa

Halwan, C, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Integrative in vitro - in silico evaluation of β-carotene-loaded nanoliposomes for targeted therapy against prostate carcinoma (PC-3) cells.

Integrative in vitro - in silico evaluation of β-carotene-loaded nanoliposomes for targeted therapy against prostate carcinoma (PC-3) cells.

Journal: Therapeutic delivery

Published: July 08, 2026

Biophysical and biological evaluation of free and liposomal doxorubicin and β-carotene reveals enhanced therapeutic selectivity in MCF-7 breast cancer cells.

Biophysical and biological evaluation of free and liposomal doxorubicin and β-carotene reveals enhanced therapeutic selectivity in MCF-7 breast cancer cells.

Journal: Journal of liposome research

Published: May 12, 2026

Correction: PEGylated liposomal metformin overcomes pharmacokinetic barriers to trigger potent mitochondrial disruption and cell cycle arrest in hepatocellular carcinoma.

Correction: PEGylated liposomal metformin overcomes pharmacokinetic barriers to trigger potent mitochondrial disruption and cell cycle arrest in hepatocellular carcinoma.

Journal: Scientific reports

Published: October 29, 2025

Liposomal formulation of Fagonia arabica L. enhances antithrombotic efficacy: phytochemical, pharmacological, and computational investigations.

Liposomal formulation of Fagonia arabica L. enhances antithrombotic efficacy: phytochemical, pharmacological, and computational investigations.

Journal: RSC advances

Published: August 25, 2025

Development and Characterization of PEGylated β-Carotene-Loaded Liposomes as Radiosensitizers in HepG2 Hepatocellular Carcinoma Cells: In Vitro and In Silico Studies.

Development and Characterization of PEGylated β-Carotene-Loaded Liposomes as Radiosensitizers in HepG2 Hepatocellular Carcinoma Cells: In Vitro and In Silico Studies.

Journal: Anti-cancer agents in medicinal chemistry

Published: August 14, 2025

Quinolone-inspired MCM2-7 helicase inhibitors: Computational design, dynamic stability, and preclinical promise for targeted anticancer therapy.

Quinolone-inspired MCM2-7 helicase inhibitors: Computational design, dynamic stability, and preclinical promise for targeted anticancer therapy.

Journal: Journal of molecular graphics & modelling

Published: August 09, 2025

Integrated experimental and computational study reveals enhanced antimicrobial efficacy of amoxicillin loaded in oleic acid nanoemulsion against multidrug-resistant Salmonella typhimurium.

Integrated experimental and computational study reveals enhanced antimicrobial efficacy of amoxicillin loaded in oleic acid nanoemulsion against multidrug-resistant Salmonella typhimurium.

Journal: RSC advances

Published: July 18, 2025

Cholesterol-dependent modulation of CD147 transmembrane dimer dynamics: Comparative 150-ns all-atom MD simulations in membrane bilayers.

Cholesterol-dependent modulation of CD147 transmembrane dimer dynamics: Comparative 150-ns all-atom MD simulations in membrane bilayers.

Journal: Biochemical and biophysical research communications

Published: July 18, 2025

Liposomal co-delivery of β-carotene and doxorubicin for enhanced colorectal-cancer therapy.

Liposomal co-delivery of β-carotene and doxorubicin for enhanced colorectal-cancer therapy.

Journal: Scientific reports

Published: July 16, 2025

Positively charged liposomal β-carotene enhances irradiation-induced cytotoxicity against prostate carcinoma cells: an in-vitro study.

Positively charged liposomal β-carotene enhances irradiation-induced cytotoxicity against prostate carcinoma cells: an in-vitro study.

Journal: BMC cancer

Published: June 22, 2025

Liposome-chondroitin sulfate/chitosan hybrid system for combinational drug delivery of curcumin and dexamethasone: In vitro anti-cancer activities.

Liposome-chondroitin sulfate/chitosan hybrid system for combinational drug delivery of curcumin and dexamethasone: In vitro anti-cancer activities.

Journal: International journal of biological macromolecules

Published: April 08, 2025

PEGylated liposomal metformin overcomes pharmacokinetic barriers to trigger potent mitochondrial disruption and cell cycle arrest in hepatocellular carcinoma.

PEGylated liposomal metformin overcomes pharmacokinetic barriers to trigger potent mitochondrial disruption and cell cycle arrest in hepatocellular carcinoma.

Journal: Scientific reports

Published: April 06, 2025

Showing 1-12 of 41

Last Updated: 09/26/2026